Literature DB >> 4390627

The effect of some oral anticholinergics on gastric emptying, pH and osmolarity in man.

D Brömster, G Carlberger, G Lundh, J Möller, A Rosén.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1969        PMID： 4390627     DOI： 10.3109/00365526909179927

Source DB:  PubMed          Journal:  Scand J Gastroenterol        ISSN： 0036-5521            Impact factor:   2.423


× No keyword cloud information.
  7 in total

1.  Oral hyoscine butylbromide does not alter the pattern of small intestinal motor activity.

Authors:  D G Thompson; D L Wingate
Journal:  Br J Pharmacol       Date:  1981-04       Impact factor: 8.739

2.  24-hour intragastric acidity and nocturnal acid secretion in patients with duodenal ulcer during oral administration of cimetidine and atropine.

Authors:  R E Pounder; R H Hunt; S H Vincent; G J Milton-Thompson; J J Misiewicz
Journal:  Gut       Date:  1977-02       Impact factor: 23.059

3.  Effects of oral cyclotropium bromide, hyoscine N-butylbromide and placebo on gastric emptying and antral motor activity in healthy man.

Authors:  G Stacher; H Bergmann; E Havlik; G Schmierer; C Schneider
Journal:  Gut       Date:  1984-05       Impact factor: 23.059

4.  Pharmacological modulation of gastric emptying rate of solids as measured by the carbon labelled octanoic acid breath test: influence of erythromycin and propantheline.

Authors:  B D Maes; M I Hiele; B J Geypens; P J Rutgeerts; Y F Ghoos; G Vantrappen
Journal:  Gut       Date:  1994-03       Impact factor: 23.059

5.  Enhancement of the gastrointestinal absorption of hydrochlorothiazide by propantheline.

Authors:  B Beermann; M Groschinsky-Grind
Journal:  Eur J Clin Pharmacol       Date:  1978-07-30       Impact factor: 2.953

Review 6.  Pirenzepine. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic efficacy in peptic ulcer disease and other allied diseases.

Authors:  A A Carmine; R N Brogden
Journal:  Drugs       Date:  1985-08       Impact factor: 9.546

7.  Pharmacological attempts to improve the bioavailability of oral etoposide.

Authors:  S P Joel; P I Clark; L Heap; L Webster; S Robbins; H Craft; M L Slevin
Journal:  Cancer Chemother Pharmacol       Date:  1995       Impact factor: 3.333
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.